Position in IRD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,359,518
+$1,175,451 QoQ
Shares Held
330,783
+440.9% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in IRD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. IRD ranks #94 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | 290,713 | $38,586,336 | |||
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in IRD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,359,518 | 330,783 | Shares | Defined | 2026-08-14 | |
| 2023-12-31 | $184,067 | 61,152 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $201,368 | 60,110 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $151,170 | 34,832 | Shares | Defined | 2023-08-14 | |
| 2021-12-31 | $39,743 | 10,655 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $102,405 | 19,395 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $60,220 | 10,365 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $127,022 | 19,572 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||